Loading...
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
BACKGROUND: Current approaches of drug repurposing against COVID-19 have not proven overwhelmingly successful and the SARS-CoV-2 pandemic continues to cause major global mortality. SARS-CoV-2 nsp12, its RNA polymerase, shares homology in the nucleotide uptake channel with the HCV orthologue enzyme N...
Na minha lista:
| Udgivet i: | J Antimicrob Chemother |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8083231/ https://ncbi.nlm.nih.gov/pubmed/33880524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkab072 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|